Relative assays

The extent to which a compound produces a response in an assay, relative to the high and low assay controls. When the compound increases the signal up to 100% or decreases the signal down to 0%, it has a 100% efficacy. When the plateau reaches another intermediary efficacy value, the compound is said to have a partial effect. 

Silzel et al. then compared the mass assay relative to the ambient analyte assay based upon a hypothehcal assay for TSH (Figure 6.6) and fmmd a 60-fold improvement in absolute fluorescent signal when using the mass-sensing approach. For example, with TSH at a concentration of 10 M (60,000 TSH molecules) and an anti-TSH capture antibody with a 10 ,... 

All potencies are relative to a-MSH In dose-response assays. Relative potency cone, of a-MSH at 50Z responae/conc. of peptide at 50Z response. The cyclic peptides 11 and 12 have much higher minimal effective dose potencies ( 10,000) In the frog skin system. 

Fig. 5. Activities of 654 active clones from the shuffled subtilisin library compared to twenty-six parents. Relative activities of each clone in five screens are plotted as concentric circles. Each color represents one of the five screening conditions pH5.5 (orange), pH7.5 (blue), pHIO (dark red), thermostability (yellow), and activity in 35% DMF at pH 7.5 (green). The area of the circle is proportional to the activity in the five assays relative to the best parent in each assay.

Existence of a reference standard used in a compendial procedure can in effect transfer the quality standard from print to the contents of the reference standard vial. Specifically, the content of the drug product is assayed relative to the USP Reference Standard, which is taken to be 100%. The late C.A. Johnson was fond of stating that the printed standard turning yellow was not the same as a yellowing reference standard. 

Despite the information about RNase H and the demonstration that many oligonucleotides may activate RNase H in lysate and purified enzyme assays, relatively little is yet known about the role of structural features in RNA targets inactivating RNase H( 146-148). In fact, direct proof that RNase H activation is the mechanism of action of oligonucleotides in cells has until very recently been lacking. 

Biomarker assays (as other bioassays) may be classified into definitive quantitative assays, relative quantitative assays, quasi-quantitative assays, and qualitative assays with varying degrees of validation requirements (Table 5.5-3) [14, 15]. For definitive quantitative assays, a well-defined or characterized standard of the biomarker is available. In the case of relative quantitative assays, calibration is performed with a standard that is not well characterized, not available in pure form, or not representative of the endogenous biomarker. Results from these assays are... 

Parameter Definitive Quantitative Assay Relative Quantitative Assay Quasi- Quantitative Assay Qualitative Assay... 

As shown above, a broad optimization effort for the 9-position had led to the identification of p-chlorobenzamide as the best substituent ( 147, entry 63 in Table 7). Because the sheer enlargement of the hydrophobic group in the 2-position did not exhibit improved affinities (entries 6-12 in Table 7), the electron densities of the aromatic aglycones were altered in a next step (entries 4-9, Table 8) [81]. Then, with the substituents in the 2- and 9-positions set, a further optimization of the acyl group in the 5-position was conducted (entries 10-16). The binding properties of the neuraminic acid derivatives 155-167 again were evaluated with the hapten binding assay relative to sialoside 147. In addition, the dissociation constants Kjj were determined in a surface plasmon resmiance (SPR) based biosensor (Biacore) experiment [70]. 

Figure 2. Effects of ribozyme-expression plasmids specific for cleavage of CBP mRNA on the levels of CBP in a transient-expression assay. Relative levels of CBP were compared by an amplified sandwich ELISA. Normalized levels of CBP in wild-type (WT) F9 cells were taken arbitrarily as 100%. All values are the averages of results from at least three experiments and the standard deviation for each value relative to the value for WT cells is indicated.

Hydrochloric acid [7647-01-0], which is formed as by-product from unreacted chloroacetic acid, is fed into an absorption column. After the addition of acid and alcohol is complete, the mixture is heated at reflux for 6—8 h, whereby the intermediate malonic acid ester monoamide is hydroly2ed to a dialkyl malonate. The pure ester is obtained from the mixture of cmde esters by extraction with ben2ene [71-43-2], toluene [108-88-3], or xylene [1330-20-7]. The organic phase is washed with dilute sodium hydroxide [1310-73-2] to remove small amounts of the monoester. The diester is then separated from solvent by distillation at atmospheric pressure, and the malonic ester obtained by redistillation under vacuum as a colorless Hquid with a minimum assay of 99%. The aqueous phase contains considerable amounts of mineral acid and salts and must be treated before being fed to the waste treatment plant. The process is suitable for both the dimethyl and diethyl esters. The yield based on sodium chloroacetate is 75—85%. Various low molecular mass hydrocarbons, some of them partially chlorinated, are formed as by-products. Although a relatively simple plant is sufficient for the reaction itself, a si2eable investment is required for treatment of the wastewater and exhaust gas. 

Assays using equiUbrium (end point) methods are easy to do but the time requited to reach the end point must be considered. Substrate(s) to be measured reacts with co-enzyme or co-reactant (C) to produce products (P and Q) in an enzyme-catalyzed reaction. The greater the consumption of S, the more accurate the results. The consumption of S depends on the initial concentration of C relative to S and the equiUbrium constant of the reaction. A change in absorbance is usually monitored. Changes in pH and temperature may alter the equiUbrium constant but no serious errors are introduced unless the equihbrium constant is small. In order to complete an assay in a reasonable time, for example several minutes, the amount and therefore the cost of the enzyme and co-factor maybe relatively high. Sophisticated equipment is not requited, however. 

The development of easy-to-use assays for determining theophylline blood levels afforded a handle on maintenance of effective but nontoxic levels. The relatively good availabihty of such assays in the United States probably contributed to the historical preference for theophylline treatment by U.S. physicians. Careful titration of the dose must be done on a patient-by-patient basis because individual rates of metaboHsm vary widely. Most ( 85%) of an oral dose of theophylline is metabolized by Hver microsomal enzymes. As a result many dmgs, eg, cimetidine [51481-61-9], anticonvulsants, or conditions, eg, fever, cigarette smoking, Hver disease, which affect Hver function alter theophylline blood levels. 

Finally, some amphiphilic sweeteners, eg, aspartame, saccharin, and neohesperidin dihydrochalcone, have been shown to be capable of stimulating a purified G-protein direcdy in an in vitro assay (136). This suggests some sweeteners may be able to cross the plasma membrane and stimulate the G-protein without first binding to a receptor. This type of action could explain the relatively longer response times and the lingering of taste associated with many high potency sweeteners. 

A study was conducted to measure the concentration of D-fenfluramine HCl (desired product) and L-fenfluramine HCl (enantiomeric impurity) in the final pharmaceutical product, in the possible presence of its isomeric variants (57). Sensitivity, stabiUty, and specificity were enhanced by derivatizing the analyte with 3,5-dinitrophenylisocyanate using a Pirkle chiral recognition approach. Analysis of the caUbration curve data and quaUty assurance samples showed an overall assay precision of 1.78 and 2.52%, for D-fenfluramine HCl and L-fenfluramine, with an overall intra-assay precision of 4.75 and 3.67%, respectively. The minimum quantitation limit was 50 ng/mL, having a minimum signal-to-noise ratio of 10, with relative standard deviations of 2.39 and 3.62% for D-fenfluramine and L-fenfluramine. 

Spectrophotometric deterrnination at 550 nm is relatively insensitive and is useful for the deterrnination of vitamin B 2 in high potency products such as premixes. Thin-layer chromatography and open-column chromatography have been appHed to both the direct assay of cobalamins and to the fractionation and removal of interfering substances from sample extracts prior to microbiological or radioassay. Atomic absorption spectrophotometry of cobalt has been proposed for the deterrnination of vitamin B 2 in dry feeds. Chemical methods based on the estimation of cyanide or the presence of 5,6-dimethylben2irnida2ole in the vitamin B 2 molecule have not been widely used. 

The development of rehable uv analysis permitted the dependable detection and assay of the provitamins and vitamins. Prior to this, the Lieberman-Bouchard chemical test was used, but the color reaction gave many false positives and was relatively inaccurate. 

The biological activity of various vitamin E forms was estabUshed by the fetal resorption assay ia tats and is assumed to be appHcable to humans. The results of some human studies may iadicate that the ratio of 1.36 underestimates the biological activity of the RRR form relative to the all-rac form of a-tocopheryl acetate (10—12). 

The classical method for the determination of vitamin K is based on the clotting time of a vitamin K-deficient chick. It is relatively easy to produce a hemorraghic state ia chicks (17). Vitamin K-deficient tats have also been used for this assay (18). Owiag to the development of modem chromatographic techniques, this method of analysis has been supplanted by other methodology. 

Automated methods are more rehable and much more precise than the average manual method dependence on the technique of the individual technologist is eliminated. The relative precision, or repeatabiUty, measured by the consistency of the results of repeated analyses performed on the same sample, ranges between 1% and 5% on automated analy2ers. The accuracy of an assay, defined as the closeness of the result or of the mean of repHcate measurements to the tme or expected value (4), is also of importance in clinical medicine. 

---